Viscosupplementation Device – Medical Devices Pipeline Assessment, 2017

Viscosupplementation Devices are used in the process by which the synovial fluid at the joints is replaced by an Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. Viscosupplementation is used for the treatment of osteoarthritis of knee and other joints. Other joints include hip, shoulder, ankle, elbow, wrist, hand and foot. Viscosupplementation consists of a treatment cycle of Hyaluronic acid injections which come in variable volumes. GlobalData's Medical Devices sector report, “Viscosupplementation Device – Medical Devices Pipeline Assessment, 2017" provides comprehensive information about the Viscosupplementation Device pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Viscosupplementation Device Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Viscosupplementation Device under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Viscosupplementation Device pipeline products.

Review of Recent Developments in the segment / industry

The Viscosupplementation Device Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Viscosupplementation Device under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023

• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape

• 56,000+ medical equipment company profiles

• 4,300+ company profiles of medical equipment manufacturers in China and India

• 2,000+ company profiles of medical equipment manufacturers in Japan

• 825+ companies’ revenue splits and market shares

• 1,900+ quarterly and annual medical equipment company financials

• 940+ medical equipment company SWOTs

• 21,500+ pipeline product profiles

• 34,500+ marketed product profiles

• 36,000+ clinical trials

• 36,500+ trial investigators

• 5,400+ reports on companies with products in development

• 33,000+ deals in the medical equipment industry

• 1,300+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Companies mentioned

Ampio Pharmaceuticals Inc

Anika Therapeutics Inc

BioTime Inc

Bioventus LLC

Carticept Medical, Inc.

Chi2Gel Ltd.

Cocoon Biotech, Inc.

DePuy Synthes Inc

Flex Biomedical Inc

Hanmi Pharmaceuticals Co Ltd

Kalvista Pharmaceuticals Inc

Moebius Medical Ltd

OPKO Health Inc

Shanghai Haohai Biological Technology Co Ltd

Spring Therapeutics

Synolyne Pharma

University of Kansas

Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Viscosupplementation Device Overview 6

3 Products under Development 7

3.1 Viscosupplementation Device – Pipeline Products by Stage of Development 7

3.2 Viscosupplementation Device – Pipeline Products by Segment 8

3.3 Viscosupplementation Device – Pipeline Products by Territory 9

3.4 Viscosupplementation Device – Pipeline Products by Regulatory Path 10

3.5 Viscosupplementation Device – Pipeline Products by Estimated Approval Date 11

3.6 Viscosupplementation Device – Ongoing Clinical Trials 12

4 Viscosupplementation Device – Pipeline Products under Development by Companies 13

4.1 Viscosupplementation Device Companies – Pipeline Products by Stage of Development 13

4.2 Viscosupplementation Device – Pipeline Products by Stage of Development 14

5 Viscosupplementation Device Companies and Product Overview 15

5.1 Ampio Pharmaceuticals Inc Company Overview 15

5.1.1 Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Anika Therapeutics Inc Company Overview 18

5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 BioTime Inc Company Overview 23

5.3.1 BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Bioventus LLC Company Overview 25

5.4.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Carticept Medical, Inc. Company Overview 26

5.5.1 Carticept Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Chi2Gel Ltd. Company Overview 27

5.6.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Cocoon Biotech, Inc. Company Overview 28

5.7.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 DePuy Synthes Inc Company Overview 29

5.8.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Flex Biomedical Inc Company Overview 30

5.9.1 Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Hanmi Pharmaceuticals Co Ltd Company Overview 31

5.10.1 Hanmi Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 Kalvista Pharmaceuticals Inc Company Overview 33

5.11.1 Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Moebius Medical Ltd Company Overview 36

5.12.1 Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 OPKO Health Inc Company Overview 37

5.13.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Shanghai Haohai Biological Technology Co Ltd Company Overview 38

5.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Spring Therapeutics Company Overview 39

5.15.1 Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Synolyne Pharma Company Overview 40

5.16.1 Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 University of Kansas Company Overview 41

5.17.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 41

6 Viscosupplementation Device – Recent Developments 42

6.1 May 08, 2017: HYMOVIS: An Innovation in HA-Based Viscoelastic Hydrogel Technology in the Treatment of Osteoarthritis Knee Pain 42

6.2 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report 42

6.3 May 03, 2017: Anika Reports First Quarter 2017 Financial Results 44

6.4 Apr 28, 2017: Lennart Johansson to Join BONESUPPORT Board of Directors 45

6.5 Apr 24, 2017: Bioventus Names David Varner Vice President of Marketing, Active Healing Therapies 45

6.6 Apr 11, 2017: BONESUPPORT Appoints Michael Diefenbeck as Chief Medical Officer 46

6.7 Mar 22, 2017: HYMOVIS Demonstrates Superior Biomechanical Lubricating Properties 46

6.8 Mar 20, 2017: Ampio Pharmaceuticals Provides Corporate Update 47

6.9 Mar 16, 2017: KalVista Pharmaceuticals Reports Fiscal Third Quarter Results 47

6.10 Mar 09, 2017: KalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of Medical 48

6.11 Feb 27, 2017: Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion for the Treatment of Pain Due to Severe Osteoarthritis of the Knee 49

6.12 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 49

6.13 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 50

6.14 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 51

6.15 Feb 09, 2017: Smith & Nephew: Directorate Change 57

6.16 Feb 08, 2017: OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis 57

6.17 Feb 03, 2017: SEIKAGAKU: Consolidated Financial Results for the First Nine Months of Fiscal 2016 57

6.18 Feb 01, 2017: Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis 59

6.19 Jan 17, 2017: Bioventus Selects MEDSERVICE to Distribute DUROLANE in Russia 59

6.20 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 60

6.21 Jan 06, 2017: BONESUPPORT CEO Richard Davies to present at Medtech Showcase 2017 60

6.22 Dec 21, 2016: Bjorn Westberg to Join BONESUPPORT as Chief Financial Officer 60

6.23 Dec 20, 2016: Appointment of Nestle Skin Health CEO ad interim 61

6.24 Dec 19, 2016: Anika Wins CE Mark Approval For ORTHOVISC-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury 61

6.25 Dec 16, 2016: BONESUPPORT Confirms Election of Dr. Hakan Bjorklund as Chairman of the Board 62

6.26 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 62

6.27 Nov 14, 2016: Bioventus Expands to Mexico with DUROLANE for Knee Osteoarthritis Patients 63

6.28 Nov 10, 2016: HYMOVIS Receives Permanent, Product-Specific J-Code from the Center for Medicare and Medicaid Services 63

6.29 Nov 08, 2016: Seikagaku Announces Exclusive Distributorship Agreement in the U.S. for VISCO-3, A Three-Injection Viscosupplement Product 64

6.30 Nov 07, 2016: Bioventus Appoints Andrew McCartney Managing Director, International for EMEA 64

6.31 Nov 07, 2016: BONESUPPORT Announces Key Corporate Appointment To Drive Growth In North America 65

6.32 Nov 03, 2016: Lattice Biologics Inks Strategic Partnerships With OA Centers of America, Resilience, and Cryoport 65

6.33 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 66

6.34 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 67

6.35 Aug 30, 2016: Ampio Reports Additional Peer-Reviewed Publication on Ampion 68

6.36 Aug 03, 2016: Ampio Updates Regulatory Status Of AMPION 69

6.37 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 69

6.38 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results 72

6.39 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 73

6.40 Jul 05, 2016: Fidia Presents New Data on Hymovis, a Breakthrough in Viscoelastic Technology, at the American Orthopaedic Society for Sports Medicine 2016 Annual Meeting 73

6.41 Jul 01, 2016: Bioventus Extends Distribution Agreement for SUPARTZ FX 74

6.42 Jun 30, 2016: Ampio Announces Results of Ampion Trials 74

6.43 Jun 24, 2016: Michael Minogue Named to Bioventus Board of Managers 75

7 Appendix 77

7.1 Methodology 77

7.2 About GlobalData 80

7.3 Contact Us 80

7.4 Disclaimer 80

List of Tables

Table 1: Viscosupplementation Device – Pipeline Products by Stage of Development 7

Table 2: Viscosupplementation Device – Pipeline Products by Segment 8

Table 3: Viscosupplementation Device – Pipeline Products by Territory 9

Table 4: Viscosupplementation Device – Pipeline Products by Regulatory Path 10

Table 5: Viscosupplementation Device – Pipeline Products by Estimated Approval Date 11

Table 6: Viscosupplementation Device – Ongoing Clinical Trials 12

Table 7: Viscosupplementation Device Companies – Pipeline Products by Stage of Development 13

Table 8: Viscosupplementation Device – Pipeline Products by Stage of Development 14

Table 9: Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 14: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 25: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 28: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 25

Table 31: Carticept Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 34: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 37: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 40: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 43: Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 46: Hanmi Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 51: Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 60: Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 63: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Table 66: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Table 69: Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 39

Table 72: Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview 40

Table 75: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 41

Table 78: Glossary 79

List of Figures

Figure 1: Viscosupplementation Device – Pipeline Products by Stage of Development 7

Figure 2: Viscosupplementation Device – Pipeline Products by Segment 8

Figure 3: Viscosupplementation Device – Pipeline Products by Territory 9

Figure 4: Viscosupplementation Device – Pipeline Products by Regulatory Path 10

Figure 5: Viscosupplementation Device – Pipeline Products by Estimated Approval Date 11

Figure 6: Viscosupplementation Device – Ongoing Clinical Trials 12

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports